Dr. Jeremiah Andrew Alt, MD, PhD

Dr. Alt practices at University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah.

Dr. Alt's NPI, 1598968380, was assigned on June 7, 2007. Dr. Alt graduated from Medical College Of Wisconsin in 2007. Dr. Alt holds Oregon license MD156611.

Dr. Alt's primary practice is University of Utah Hospitals and Clinics - Unit, at 50 North Medical Drive, Salt Lake City, UT 84132 in Salt Lake County. The practice phone is (801) 581-2337.

Dr. Alt's primary practice is University of Utah Hospitals and Clinics - Unit in Salt Lake City, Utah. Dr. Alt is also affiliated with University of Utah Hospital. The medical group on file is University of Utah Health. Dmand AI also links Dr. Alt to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alt practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Alt's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Alt is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Alt's licenses on file in 7 states: Oregon, Florida, Nevada, Utah, Wyoming, Idaho and Montana.

Dmand AI lists acute sinusitis, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders and endoscopic sinus surgery among the conditions Dr. Alt treats.

CMS data shows 316 Medicare services from Dr. Alt across 7 procedure codes in 2024, for 114 Medicare patients. Medicare paid $30,177 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 114 Medicare patients who saw Dr. Alt in 2024. The largest group is 65 to 74, with 66 patients. 67% of them have high cholesterol, and 63% have high blood pressure. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alt's median patient age at 69, with 49% women.

In 2024, Dr. Alt wrote 207 Medicare Part D claims for 68 patients. 94% of them were for generic drugs. CMS names the drug for 135 of them, across 5 drugs with 11 or more claims each, at $2,246 in total drug cost. In 2023, CMS named 125 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Alt for performance year 2024, reported as part of a group. Dr. Alt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alt as offering telehealth.

Dmand AI links 134 papers to Dr. Alt, published from 2002 to 2025. 2016 was the busiest year, with 13. The most frequent topics are Sinusitis, Rhinitis and Endoscopy. Dr. Alt has published most often in Int Forum Allergy Rhinol. Dr. Alt's most frequent co-authors are Richard R. Orlandi, MD, Amarbir Singh Gill, MD and Zachary Michael Soler, MD.

CMS Open Payments shows 173 general payments to Dr. Alt from 16 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 67% of the total. GlaxoSmithKline, LLC. paid the most, $35,292. It also lists 1 research payment totaling $5,000 in 2016.

Dmand AI lists 1 award for Dr. Alt. Dr. Alt serves on ARS Fellowship RTC and ARS Education Committee.

Dr. Alt graduated from Medical College Of Wisconsin in 2007. Dr. Alt is a member of NHS, ACS and AMA.

Dr. Alt is in network with 18 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.